1,948
Views
14
CrossRef citations to date
0
Altmetric
Retraction

RETRACTED ARTICLE: MicroRNA-624-mediated ARRDC3/YAP/HIF1α axis enhances esophageal squamous cell carcinoma cell resistance to cisplatin and paclitaxel

ORCID Icon, , &
Pages 5334-5347 | Received 25 Feb 2021, Accepted 31 May 2021, Published online: 20 Aug 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ting Huang, Lijuan Tang, Huan Wang, Lu Lin & Jing Fu. (2021) Carbonic anhydrase 12 gene silencing reverses the sensitivity of paclitaxel in drug-resistant breast cancer cells. Bioengineered 12:2, pages 9806-9818.
Read now

Articles from other publishers (12)

Aidi Gao, Mingxia Zhang, Shuang qi Zhu, Shitao Zou, Hengrui Chen, Xiaoqin Li, Chao He, Liangsu Zhou, Yan Mei, Weiqun Ding, Jundong Zhou, Yue Zhou & Yuandong Cao. (2024) DNA polymerase iota promotes EMT and metastasis of esophageal squamous cell carcinoma by interacting with USP7 to stabilize HIF-1α. Cell Death & Disease 15:2.
Crossref
Jiaxin Wu, Yuanying Wang, Yi Cheng, Li Cheng & Lushun Zhang. (2024) Comprehensive landscape and future perspectives of non-coding RNAs in esophageal squamous cell carcinoma, a bibliometric analysis from 2008 to 2023. Pathology and Oncology Research 30.
Crossref
Lin Gao, Li Li, Dongmei Zhang, Jianwei Qiu, Junbo Qian & Hongbin Liu. (2023) TAPI-1 Exhibits Anti-tumor Efficacy in Human Esophageal Squamous Cell Carcinoma Cells via Suppression of NF-κB Signaling Pathway. Digestive Diseases and Sciences 69:1, pages 81-94.
Crossref
Liya Hu, Hong Cao, Lijun Zheng & Ruichao Li. (2023) BBOX1-AS1 Activates Hedgehog Signaling Pathway to Facilitate the Proliferation and Stemness of Esophageal Squamous Cell Carcinoma Cells via miR-506-5p/EIF5A/PTCH1 Axis. Current Molecular Pharmacology 16:8.
Crossref
Xue-Wei Wang, Zi-Yi Yang, Ting Li, Xin-Ran Zhao, Xiao-Zhong Li & Xiao-Xia Wang. (2023) Verteporfin Exerts Anticancer Effects and Reverses Resistance to Paclitaxel via Inducing Ferroptosis in Esophageal Squamous Cell Cancer Cells. Molecular Biotechnology.
Crossref
Yoshinori Fujita, Yujiro Fukuda, Fumiaki Sanuki, Isao Irei, Yasumasa Monobe, Masako Uno, Takeshi Akisada, Koichiro Shimoya, Hirotaka Hara & Takuya Moriya. (2023) Protease-Activated Receptor 1 (PAR1) Expression Contributes to HPV-Associated Oropharyngeal Cancer Prognosis. Head and Neck Pathology 17:3, pages 658-672.
Crossref
Yusuke Takashima, Shuhei Komatsu, Takuma Ohashi, Jun Kiuchi, Keiji Nishibeppu, Hajime Kamiya, Hiroshi Arakawa, Ryo Ishida, Hiroki Shimizu, Tomohiro Arita, Hirotaka Konishi, Atsushi Shiozaki, Takeshi Kubota, Hitoshi Fujiwara & Eigo Otsuji. (2023) Plasma miR ‐1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer . Cancer Science 114:7, pages 3027-3040.
Crossref
Lin Li, Hangyu Jiang, Yuqi Li, Xiaochong Xiang, Yueming Chu, Jie Tang, Kang Liu, Danqun Huo & Xiaofen Zhang. (2023) Chaetocin exhibits anticancer effects in esophageal squamous cell carcinoma via activation of hippo pathway. Aging.
Crossref
Ahmed S. Doghish, Ahmed A. El-Husseiny, Nourhan M. Abdelmaksoud, Hesham A. El-Mahdy, Elsayed G.E. Elsakka, Sherif S. Abdel Mageed, Abdulla M.A. Mahmoud, Ahmed Amr Raouf, Mohammed S. Elballal, Walaa A. El-Dakroury, Mohamed M.M. AbdelRazek, Mina Noshy, Hussein M. El-Husseiny & Ahmed I. Abulsoud. (2023) The interplay of signaling pathways and miRNAs in the pathogenesis and targeted therapy of esophageal cancer. Pathology - Research and Practice 246, pages 154529.
Crossref
Mehrdad Hashemi, Mohammad Arad Zandieh, Yasmin Talebi, Parham Rahmanian, Sareh Sadat Shafiee, Melina Maghsodlou Nejad, Roghayeh Babaei, Farzaneh Hasani Sadi, Romina Rajabi, Zahra Oryan Abkenar, Shamin Rezaei, Jun Ren, Noushin Nabavi, Ramin Khorrami, Mohsen Rashidi, Kiavash Hushmandi, Maliheh Entezari & Afshin Taheriazam. (2023) Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies. Biomedicine & Pharmacotherapy 160, pages 114392.
Crossref
Zhi Yang, Rui Ma, Jie Li & Lina Zhao. (2023) Noncoding RNAs in esophageal cancer: A glimpse into implications for therapy resistance. Pharmacological Research 188, pages 106678.
Crossref
Wei Su, Hao Hu, Qiurong Ding, Min Wang, Yan Zhu, Zhaochao Zhang, Zihan Geng, Shengli Lin & Pinghong Zhou. (2022) NEK2 promotes the migration and proliferation of ESCC via stabilization of YAP1 by phosphorylation at Thr-143. Cell Communication and Signaling 20:1.
Crossref